findmyKOL
Clinical trialNCT02580877CompletedPhase 2Interventional

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrollment92Type 1 Diabetes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Walter and Eliza Hall Institute of Medical Research

    Parkville, Victoria, Australia

Canada
  • the Hospital for Sick Children

    Toronto, Ontario, Canada

Italy
  • San Raffaele Hospital

    Milan, Italy

United States
  • University of California - San Francisco

    San Francisco, California, United States

  • Stanford University

    Stanford, California, United States

  • Barbara Davis Center for Childhood Diabetes

    Aurora, Colorado, United States

  • University of Florida

    Gainesville, Florida, United States

  • University of Miami

    Miami, Florida, United States

  • University of South Florida

    Tampa, Florida, United States

  • Emory Children'S Center

    Atlanta, Georgia, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Indiana University-Riley Hospital for Children

    Indianapolis, Indiana, United States

  • Joslin Diabetes Center

    Boston, Massachusetts, United States

  • Columbia University-Naomi Berrie Diabetes Center

    New York, New York, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

  • University of Texas Southwestern

    Dallas, Texas, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • Benaroya Research Institute

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2016
Primary completion
31 Mar 2018
Completion
31 Mar 2018
Last update posted
27 Jul 2020
Registered enrollment
92
Registry id
NCT02580877

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.